Suchergebnisse - (Person:"Piantoni, Silvia")

PubPharm (5)

1

Is cholecalciferol a potential disease-modifying anti-rheumatic drug for the management of rheumatoid arthritis?

enthalten in: Clinical and experimental rheumatology | 2020

von Bellan, M. | Andreoli, L. | Nerviani, A. | +6

2

Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept

enthalten in: Clinical and experimental rheumatology | 2018

von Piantoni, S. | Regola, F. | Scarsi, M. | +2

3

Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis

enthalten in: Clinical rheumatology | 2016

von Piantoni, S. | Colombo, E. | Tincani, A. | +2

4

Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abatacept

enthalten in: Clinical and experimental rheumatology | 2016

von Colombo, E. | Scarsi, M. | Piantoni, S. | +2

5

Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

enthalten in: Rheumatology international | 2015

von Piantoni, S. | Scarsi, M. | Tincani, A. | +1

1
[1]